Product image of Minoplus (Minocycline Hydrochloride) supplied by GNH India

Minoplus

Active Ingredient:
Minocycline Hydrochloride
Origin:
EU

Minoplus (Minocycline Hydrochloride)

Minocycline, the active ingredient in Minoplus, is a tetracycline antibiotic presented as an oral tablet for oral use. It treats bacterial infections such as acne vulgaris, respiratory tract infections, urinary tract infections, and skin and soft‑tissue infections in adults and adolescents.

GNH India supplies Minoplus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑compliant documentation for global distribution.

Manufacturer / TM Owner

Chephasaar Chemisch-Pharmazeutische Fabrik Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minocycline is a tetracycline antibiotic used to treat bacterial infections affecting the skin, respiratory system, urinary tract, and related tissues.

  • Acne vulgaris: reduces inflammatory lesions and bacterial colonization of the skin.
  • Respiratory tract infections: combats susceptible strains causing sinusitis, bronchitis and pneumonia.
  • Urinary tract infections: eradicates common uropathogens such as Escherichia coli.
  • Skin and soft tissue infections: treats cellulitis, wound infections and other dermal bacterial conditions.

How It Works

  • Minocycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking the attachment of amino‑acyl tRNA to the mRNA‑ribosome complex. This prevents elongation of the nascent peptide chain, producing a bacteriostatic effect against a broad spectrum of Gram‑positive and Gram‑negative organisms. The drug penetrates well into tissues and intracellular compartments, enhancing its effectiveness in skin and soft‑tissue infections.

Side Effects

Minocycline may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Diarrhea: loose stools.
  • Dizziness: transient light‑headedness.
  • Photosensitivity: increased skin reaction to sunlight.
  • Hyperpigmentation: darkening of skin or mucous membranes.
  • Vestibular disturbances: vertigo or balance issues.

Serious or Rare Side Effects

  • Stevens‑Johnson syndrome: severe skin and mucosal reactions.
  • Drug‑induced hepatitis: elevated liver enzymes or jaundice.
  • Autoimmune hepatitis: immune‑mediated liver injury.
  • Pseudotumor cerebri: increased intracranial pressure.
  • Severe hypersensitivity: anaphylaxis or angioedema.
  • Hematologic abnormalities: aplastic anemia, neutropenia.

Precautions & Warnings

Before prescribing Minoplus, clinicians should consider several safety precautions to minimize risk.

  • Renal impairment: adjust therapy and monitor kidney function.
  • Hepatic disease: use with caution and assess liver enzymes.
  • Pregnancy: avoid unless benefits outweigh potential risks.
  • Concomitant oral contraceptives: efficacy may be reduced; advise alternative contraception.
  • Age > 8 years: not recommended for children under eight years due to tooth discoloration risk.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container.

Avoid Interactions

Minocycline can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Warfarin: increased anticoagulant effect, risk of bleeding.
  • Isotretinoin: heightened risk of intracranial hypertension.
  • Antacids containing aluminum or magnesium: reduce absorption of minocycline.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: decreased hormonal effectiveness.
  • Cyclosporine: increased nephrotoxicity potential.
  • Phenytoin: may lower minocycline levels, reducing efficacy.
  • Vitamin D supplements: may increase risk of hypercalcemia.

Frequently Asked Questions

Minoplus contains minocycline, a tetracycline antibiotic indicated for acne vulgaris, respiratory tract infections such as sinusitis and bronchitis, urinary tract infections caused by susceptible bacteria, and skin and soft‑tissue infections including cellulitis and wound infections.

Minocycline blocks bacterial protein synthesis by binding to the 30S ribosomal subunit. This prevents the attachment of amino‑acyl tRNA to the ribosome, halting peptide chain elongation and resulting in a bacteriostatic effect against a broad range of Gram‑positive and Gram‑negative organisms.

The dosage of Minoplus is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and local treatment guidelines. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for minocycline in pregnancy and lactation are limited. It is generally avoided during pregnancy unless the potential benefit justifies the risk, and caution is advised for breastfeeding mothers because the drug can be excreted in breast milk.

To request Minoplus, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minoplus (minocycline) offers a broader tissue penetration and a longer half‑life than doxycycline, allowing once‑ or twice‑daily dosing. It is also more lipophilic, which can enhance efficacy in skin and soft‑tissue infections, but it may have a higher incidence of vestibular side effects compared with some other tetracyclines.

Minoplus should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf life.

Minoplus is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids containing aluminum or magnesium, as these can reduce absorption.

Serious risks include severe hypersensitivity reactions such as Stevens‑Johnson syndrome, drug‑induced or autoimmune hepatitis, intracranial hypertension (pseudotumor cerebri), and hematologic disorders like aplastic anemia or neutropenia. Patients should seek immediate medical attention if they experience rash, jaundice, severe headache, visual changes, or unexplained bruising.

Minoplus is contraindicated in patients with known hypersensitivity to minocycline or other tetracyclines, in children younger than eight years due to risk of tooth discoloration, and in pregnant women unless the therapeutic benefit outweighs potential fetal risk. Caution is also advised for individuals with severe renal or hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Minocycline Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT